4-(n,n-dimethylaminosulphonyl)-7-(1-piperazinyl)-2,1,3-benzoxadiazole has been researched along with hsr 609 in 1 studies
| Studies (4-(n,n-dimethylaminosulphonyl)-7-(1-piperazinyl)-2,1,3-benzoxadiazole) | Trials (4-(n,n-dimethylaminosulphonyl)-7-(1-piperazinyl)-2,1,3-benzoxadiazole) | Recent Studies (post-2010) (4-(n,n-dimethylaminosulphonyl)-7-(1-piperazinyl)-2,1,3-benzoxadiazole) | Studies (hsr 609) | Trials (hsr 609) | Recent Studies (post-2010) (hsr 609) |
|---|---|---|---|---|---|
| 8 | 0 | 2 | 6 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, H; Nagata, O; Takahara, E; Yamada, T | 1 |
1 other study(ies) available for 4-(n,n-dimethylaminosulphonyl)-7-(1-piperazinyl)-2,1,3-benzoxadiazole and hsr 609
| Article | Year |
|---|---|
Sensitive analytical method for the novel H1-receptor antagonist HSR-609 in human plasma and urine by high-performance liquid chromatography with pre-column fluorescent derivatization.
Topics: Benzoxepins; Chromatography, High Pressure Liquid; Fluorescence; Histamine H1 Antagonists; Humans; Male; Oxadiazoles; Piperazines; Pyridines; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides | 1996 |